High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma

Published:2018-10-08 Issue:3 Volume:120 Page:3547-3558
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Xu He¹²,Zeng Liang³,Guan Yongjun²,Feng Xiangling⁴,Zhu Yinghong²,Lu Yichen¹²,Shi Chen¹²,Chen Shilian²,Xia Jiliang²,Guo Jiaojiao²,Kuang Chunmei²,Li Wei¹,Jin Fengyan¹,Zhou Wen²^ORCID

Affiliation:

1. Cancer Center, The First Hospital of Jilin University Changchun China

2. Cancer Research Institute, Central South University; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education; Key Laboratory of Carcinogenesis, National Health and Family Planning Commission Changsha Hunan China

3. Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha Hunan China

4. School of Public Health, Central South University Changsha Hunan China

Funder

Natural Science Foundation of Hunan Province

State Key Laboratory of Experimental Hematology

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27632